WICHITTREE HUTTON: Open Payments
NPI 1336550409 · YORK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 25 payments from 7 companies in 2025. Trend: 2023 $739 · 2024 $666 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $105 |
| Lundbeck LLC | 3 | $61 |
| Alkermes, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
Products named: VRAYLAR, CAPLYTA, REXULTI, LYBALVI, Auvelity, INGREZZA, ABILIFY ASIMTUFII.
Industry payments across PA — which companies pay providers there.
